š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
This study will evaluate GSK Biologicals' DTPa-HBV-IPV/Hib vaccine given as...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-09-23
Trial ID
NCT00753649
Treatments Being Tested
This study will assess the immunogenicity and safety of GlaxoSmithKline (GS...
Status
Completed
Location
Multiple Locations
Start Date
1999-01
Trial ID
NCT01457508
Treatments Being Tested
This study aims to evaluate the persistence of anti-poliovirus antibodies i...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-04-25
Trial ID
NCT01323647
Treatments Being Tested
This study evaluates the immunogenicity and safety of Infanrix hexaā¢ (DTPa-...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-04-16
Trial ID
NCT01353703
Treatments Being Tested
This study will evaluate the persistence of immunity to hepatitis B 10 to 1...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-06-07
Trial ID
NCT01138098
Treatments Being Tested
The primary immunogenicity objective is to assess and compare the immunogen...
Status
Completed
Location
Site 22
Start Date
2008-03
Trial ID
NCT00667602
Treatments Being Tested
The aim of this study is to assess antibody persistence in infants who rece...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-05-30
Trial ID
NCT01358825
Treatments Being Tested
The purpose of this study was to assess the safety and immunogenicity of GS...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-05-26
Trial ID
NCT04535037
Treatments Being Tested
This is a study in a large number of healthy children less than 3 years old...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-06-28
Trial ID
NCT00466947
The purpose of this study is to determine at 5 years of age the persistence...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-12
Trial ID
NCT00411697
Treatments Being Tested